Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026764 (
multiple myeloma
)
36,148
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Solitary extramedullary plasmacytoma (SEP) is a rare malignant neoplasm arising from plasma cells most commonly occurring in the nasal cavity, nasopharynx and larynx. Thyroid involvement is rare and less than 75 cases of SEP of the thyroid gland have been reported to date. A 74-year-old woman with an history of multinodular goiter presented with dysphonia and painful neck swelling, related to a rapidly growing nodule in the right thyroid lobe. Thyroid function tests showed subclinical hypothyroidism; no evidence of Hashimoto's disease was found. Ultrasound confirmed the presence of an isoechoic nodule, 35 mm in diameter, with a CDIII vascular pattern. FNAC showed a monotonous population of atypical cells, interpreted as suspicious for malignant neoplasia (Thyr. 4). The patient underwent total thyroidectomy. Histopathological examination showed a unencapsulated neoplasm composed of atypical tumour cells characterized by abundant cytoplasm and eccentric nuclei. At immunohistochemistry, tumour cells revealed diffuse reactivity for CD138 and CD45RB and predominant staining for kappa chains. Pan-cytokeratins, TTF1, thyreoglobulin, calcitonin, CD20 and CD79a were negative. Clinically, a complete
multiple myeloma
workup was negative. On this basis, a definitive diagnosis of SEP was made. At 16 months follow-up, the patient showed good clinical conditions without evidence of
multiple myeloma
. In conclusion, SEP should be considered in the differential diagnosis of a rapidly enlarging
thyroid nodule
. Clinical correlation and immunocytochemistry are crucial in avoiding pitfalls. Surgery remains the best modality of treatment whenever the lesion is localized and easily removable.
...
PMID:Solitary extramedullary plasmacytoma of the thyroid gland associated with multinodular goiter: case report and review of the literature. 2200 66
Neoplastic plasma cell involvement of thyroid is an uncommon condition, and it may involve thyroid in
multiple myeloma
or solitary plasmacytoma. Its clinical and pathological features are not well understood. We present a rare case of synchronous thyroid involvement in plasma cell leukemia presenting as
thyroid nodule
with primary hypothyroidism. Simultaneous cytology, immunocytochemistry, FISH analysis with 13q14.3 and TP53 on cytology smears and haematology workup were performed to diagnose and to understand disease pathobiology with poor outcome.
...
PMID:Synchronous Thyroid Involvement in Plasma Cell Leukemia Masquerading as Hashimoto's Thyroiditis: Role of Ancillary Cytology Techniques in Diagnostic Workup. 2633 Jan 90
Thyroid fine-needle aspiration (FNA) cytology is the primary tool for the diagnostic evaluation of thyroid nodules. BRAF mutation analysis is employed as an ancillary tool in indeterminate cases, as recommended by the American Thyroid Association management guidelines. Hereby, we report the case of a 73-year-old woman who presented an 8-mm-size, ill-defined, left
thyroid nodule
. FNA resulted "suspicious for papillary thyroid carcinoma". BRAF mutation status was analyzed, and somatic BRAF (V600E) mutation identified. The patient underwent a total thyroidectomy. At histological examination, the nodule was composed of Langerhans cells, admixed with many eosinophils. A final diagnosis of Langerhans cell histiocytosis of the thyroid was made. Our case emphasizes the critical diagnostic pitfalls due to the use of BRAF (V600E) mutation analysis in thyroid FNA. Notably, BRAF (V600E) mutation is common in melanoma, colorectal carcinoma, lung carcinoma, ovarian carcinoma, brain tumors, hairy cell leukemia,
multiple myeloma
, and histiocytoses. Therefore, in cases of indeterminate FNA with unclassifiable atypical cells BRAF (V600E) mutated, the possibility of a localization of hystiocytosis or a secondary thyroid malignancy should be taken into account.
...
PMID:Critical Pitfalls in the use of BRAF Mutation as a Diagnostic Tool in Thyroid Nodules: a Case Report. 2678 3